By Maksym Misichenko · Yahoo Finance ·
What AI agents think about this news
Nano Dimension is effectively liquidating its operational identity, with a focus on monetizing assets and pursuing a reverse merger. The company's history of value-destructive acquisitions and governance issues raise significant concerns about its ability to execute a successful turnaround.
Risk: The 'M&A poison' risk, where management's lack of operational discipline could lead to another value-destructive acquisition or reverse merger, transferring their governance failures to a new entity.
Opportunity: Monetizing the remaining product lines at credible valuations and favorable terms, which could provide the cash needed for a reverse merger and potentially turn the company around.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
Image source: The Motley Fool.
May 7, 2026 at 4:30 p.m. ET
- Chief Executive Officer — David Stehlin
- Chief Financial Officer — John Brenton
- Vice President, Investor Relations — Purva Sanariya
Need a quote from a Motley Fool analyst? Email [email protected]
Purva Sanariya: Thank you, and good afternoon, everyone. Welcome to Nano Dimension's First Quarter 2026 Earnings Conference Call. Joining me today is our CEO, Dave Stehlin; and our CFO, John Brenton. Before we begin, I will remind you that certain information provided on this call may contain forward-looking statements within the meaning of federal securities laws. Forward-looking statements are not guarantees and involve known and unknown risks, uncertainties and other factors, which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. The safe harbor statement outlined in today's earnings press release also pertains to statements made on this call.
For a discussion of these risks and uncertainties, please refer to our filings with the U.S. Securities and Exchange Commission. We undertake no obligation to update any forward-looking statements, except as required by law. In addition, I would like to point out that we will be discussing non-GAAP results, which exclude certain items and reflect the results of continuing operations. We use non-GAAP measures because we believe they provide useful information about our operating performance that should be considered by investors in conjunction with the GAAP measures that we provide.
I encourage you to review the reconciliation of these non-GAAP measures to their most directly comparable GAAP measures, which can be found in the press release available on the company's website. If you have not received a copy of the press release, please view it in the Investor Relations section of the company's website. A replay of today's call will also be available on the Investor Relations section of the company's website. With that, I will turn the call over to Dave.
David Stehlin: Thank you, Purva, and good afternoon, everyone. We appreciate you joining us today. I want to start by making as clear as possible what our strategic plan is and where we are in our process. We're now at a very clear inflection point. And today, I'll walk through what we have already accomplished, what is currently underway and what to expect going forward. I'll also take you through our 3-phase strategic plan in detail and provide an update on each phase. Before that, I'll begin with an overview of our performance in Q1.
In the first quarter, our 2 largest product lines, Fused Filament Fabrication or FFF, which represents the largest component of Markforged and Essemtec's Surface Mount Technology or SMT product line, each delivered solid revenue performances. Results were in line with typical seasonal patterns where the first quarter is historically our lightest period following a strong fourth quarter. Underlying demand trends remain healthy with continued expansion across key industry segments and strong customer engagement. In our FFF business, we secured a significant expansion with a major U.S.-based automotive manufacturer. The deployment of multiple systems across several sites reflects the growing adoption of our solutions in production-oriented environments, and we expect further expansion over time.
We also continue to see growth in defense-related opportunities across multiple applications and multiple regions, and we expect this segment to further expand throughout this year. Additionally, the Essemtec SMT product line had a solid start to the year, and we expect momentum to continue to build throughout the year. The combination of our PCB placement accuracy and flexibility, speed and high-quality engineering is winning exciting and significant new business in electronics and AI-related manufacturing, including engagements with leading global electronic manufacturing services companies serving large-scale customers. We're also seeing continued expansion in the deployment of our Essemtec solutions with leading space and satellite companies, reinforcing the applicability of our technologies in highly complex mission-critical environments.
More broadly, we continue to see strong traction across industrial production environments, including repeat orders and expansion with global customers operating at scale. These trends reflect a broader shift across industries where customers are increasingly prioritizing supply chain resilience, production flexibility and cost efficiency, areas where our technologies are well positioned. Overall, we remain confident that each of these product lines is positioned to deliver solid performances in 2026. Now turning to our 3-phase strategic plan. These phases are operating in parallel, not in series, and reflect significant actions underway across the company.
Nano Dimension today is a set of product lines built over time through acquisitions completed by prior management teams and overseen by prior boards, all within the broader digital manufacturing ecosystem. This includes both additive manufacturing or 3D printing technologies as well as electronics manufacturing technologies such as surface mount technology. Our products support some of the most advanced and fastest-growing industries, and we have an expanding base of success with companies and governments around the world.
At the same time, the Board concluded that while these product lines have strong technologies and excellent teams, the ability to fully integrate them and get strong synergies and cost reductions would be highly challenging, require significant capital investment and introduce unnecessary execution risk. As a result, we initiated the previously described strategic alternatives review process in Q3 of last year to determine how to focus on certain product lines, reduce cash burn and maximize long-term shareholder value. Earlier last year, we divested out of certain product lines. And as we started Phase 1 in Q3 of '25, we then focused on streamlining the remaining product lines, reducing operating costs while preserving growth potential and not impairing long-term value creation.
We began to see a significant reduction in cash burn in Q4 of '25, and that trend has continued into '26. As discussed in our previous updates, we've taken on meaningful actions to reduce costs, and that discipline continues. John will speak to the details, but the overall trend in operating expenses and cash burn remains favorable. Phase 2 has been underway for a few months now and includes an aggressive and detailed evaluation of our remaining operating product lines. With the support of Guggenheim Securities, one of our 2 previously announced investment banking relationships, we are presenting the Board with alternatives to support the monetization of our product lines.
Our first completed transaction was the sale of the AME and Fabrica product lines, which closed on April 6, just a month ago. This transaction reduces complexity, improves focus and lowers our cost structure. It also includes both upfront and performance-based deferred considerations, allowing us to participate in potential upside under new ownership. Importantly, this step is expected to reduce annualized cash burn by approximately $10 million while strengthening our liquidity position. As part of our ongoing strategic alternatives review process, in Q1 of this year, we identified factors that required us to perform a goodwill impairment review for the Markforged FFF product line.
As a result, we determined that the full goodwill balance associated with Markforged totaling $40.4 million was impaired as of quarter end. This is a noncash adjustment and does not impact our liquidity or execution of the plan. We're close to announcing the sale of another product line and are in the regulatory phase of approval. We expect to have more information on this in the coming weeks. We are also actively pursuing the right opportunities for each of our other product lines and expect continued progress toward our objectives in the coming weeks and months.
I previously mentioned that the 3 phases of our plan are operating in parallel, and Phase 3 is focused on maximizing long-term value in 2026 and beyond. The Board and management have been working with Houlihan Lokey to evaluate and refine a focused set of go-forward alternatives, which may include, but not limited to, a strategic merger, a reverse merger or other strategic transactions. Our financial resources and public company platform create a compelling opportunity to pursue alternatives that could unlock value that better reflects our underlying balance sheet while also delivering significant long-term upside. Over the past few months, we've been pleased to review a significant number of interesting opportunities and potential partners and have narrowed the list.
We're deep in the review process of this narrowed down and short list of exciting opportunities, and we'll present more details to our shareholders as our plan becomes firm. Again, each of these 3 phases of our plan are continuing forward, streamlining operations and cash burn reduction, product line monetization and go-forward alternative selection, and they're moving forward at a rapid pace. We expect to provide additional updates and announcements over the next few months as execution continues.
In closing, I hope that you can now more clearly see the steps in our 3-phase strategic plan initiated by this Board in late Q3 of last year, the measurable and positive results we're seeing and the potential for exciting opportunities in the near future. With that, I'll turn the call over to John to review our financial results and provide an update on guidance. John?
John Brenton: Thank you, Dave. It's a pleasure to be here with you all today. Unless stated otherwise, all numbers I will be discussing today are on a non-GAAP basis and reflect continuing operations. Revenue for the first quarter was $29.7 million, representing approximately 106% year-over-year growth compared to $14.4 million in the first quarter of 2025. This increase was driven primarily by the inclusion of Markforged, which contributed $17.1 million. Excluding Markforged, Nano Dimension stand-alone revenue was $12.6 million, lower year-over-year by approximately 12%, primarily due to reduced sales driven by increased tariffs and the impact of divestments.
Gross profit for the quarter was $13.6 million with an adjusted gross margin of approximately 45.9% compared to $6.2 million and 43.3% in the prior year period. The improvement reflects the impact of divestments and product mix. Sequentially, gross profit decreased from the fourth quarter, reflecting normal quarterly variability and product mix. Operating expenses for the quarter were $26.1 million, representing a year-over-year increase of approximately 60% from $16.3 million in the first quarter of 2025, primarily due to the inclusion of Markforged, partially offset by cost efficiencies from organizational synergies. On a stand-alone basis, Nano Dimension's operating expenses declined approximately 22% year-over-year, reflecting the benefits of divestments and disciplined cost management.
On a sequential basis, operating expenses for the first quarter declined by over 4% from $27.3 million in the fourth quarter and approximately 20% relative to the previously identified baseline of approximately $32.5 million, which reflects second quarter operating expenses adjusted to include a full quarter of Markforged. This decrease reflects continued execution on cost discipline and operational streamlining across the organization. Adjusted EBITDA for the quarter was a loss of $12.5 million compared to a loss of $10.1 million in the first quarter of 2025 and a loss of $9.8 million in the fourth quarter of 2025.
The change reflects the inclusion of Markforged and lower stand-alone revenue impacted by tariffs and divestments, partially offset by gross margin performance and continued cost discipline. Turning to the balance sheet. Our financial position remains exceptionally strong. As of March 31, 2026, total cash, cash equivalents, deposits, restricted deposits and marketable equity securities were approximately $441.6 million compared to $459.6 million at the end of the prior quarter. This change of approximately $18 million includes $8.4 million related to changes in the fair value of marketable equity securities. The remaining change of $9.6 million primarily reflects lower sequential operating cash burn.
Operating cash burn has continued to trend down since the third quarter of 2025, driven by disciplined expense management and cost reduction actions taken across the business. We continue to maintain a strong liquidity position, which provides flexibility as we execute through our defined strategic plan. Turning to guidance. Given our ongoing execution of our defined strategic plan and the potential for additional significant changes across the business, we have decided to withdraw our full year financial guidance at this time. This decision reflects the range of outcomes we are currently evaluating, including the timing and scope of potential monetization actions that could materially impact future financial results. With that, I will now hand it back to Dave.
David Stehlin: Thank you, John. As you can now see, we are executing on all phases of our plan to strengthen Nano and position the company for near- and long-term value creation. With that, operator, please open the line for questions.
Operator: [Operator Instructions] And our first question today comes from Moshe Sarfaty from Murchinson.
Moshe Sarfaty: Dave, I want to refer to what you talked about the strategic review process, especially the third part of it. You said not limited to reverse merger, et cetera. And I don't know if you noticed how many times you repeated the terms excited and exciting, but I don't know how excited and exciting it is for Nano Dimension shareholders to hear about more and more mergers done by this company. We've been burned so many times that I don't think it's very exciting to Nano shareholders. Can you comment on that?
David Stehlin: Yes, Moshe. So as you know, since the September time frame, we've engaged with our 2 different banks. And now you can see that they have different roles. And Houlihan Lokey has been focused on bringing us interesting partner opportunities. I mentioned that we have had looked at a large number, and that's more than a dozen different opportunities, and we've since narrowed that down.
And I think when we get to the point where we make a decision, and we're not that far away, when we g
Four leading AI models discuss this article
"NNDM has pivoted from an additive manufacturing company to a cash-heavy shell entity pursuing a desperate reverse merger to avoid total value erosion."
Nano Dimension is effectively liquidating its operational identity to preserve its balance sheet. With a $441.6 million cash pile and a market cap that has historically lagged its book value, the company is signaling a 'fire sale' transition. The $40.4 million goodwill impairment on Markforged is a massive red flag, suggesting the acquisition—a centerpiece of previous strategy—has already failed to generate expected synergies. With guidance withdrawn and management actively shopping the remaining product lines, NNDM is no longer an operating company; it is a SPAC-like vehicle looking for a reverse merger partner. Investors are betting on the board's ability to find a buyer or partner that values the cash and listing more than the underlying, struggling manufacturing assets.
If management successfully divests the remaining units at a premium and secures a high-growth partner for a reverse merger, the current cash-to-market-cap discount could offer significant upside for patient shareholders.
"NNDM's $442M cash buffers execution risks, but serial divestments, impairments, and merger ambiguity demand proof of value-accretive deals before any re-rating."
NNDM's Q1 showed $29.7M revenue (+106% YoY) driven by Markforged ($17.1M), but standalone fell 12% to $12.6M from tariffs/divestments; gross margins hit 45.9% while opex dropped 20% vs. baseline, trimming cash burn to $9.6M. With $442M liquidity, Phase 2 divestments (AME/Fabrica sold, another imminent saving $10M burn) simplify ops, but $40.4M Markforged goodwill impairment and withdrawn FY guidance underscore uncertainty. Phase 3 merger pursuits risk repeating past acquisition missteps, per shareholder Q&A—upside hinges on monetization multiples and deal quality.
If divestments fetch strong multiples and Phase 3 lands a high-quality merger, NNDM's cash hoard could catalyze 2-3x upside by pairing liquidity with growth assets. Standalone trends may reverse as Essemtec gains AI/defense traction.
"NNDM's $40.4M Markforged impairment and ongoing product-line fire sales reveal a failed acquisition strategy, not a turnaround, and the 'exciting alternatives' are management's admission they cannot fix what they bought."
NNDM is in full-blown breakup mode, not turnaround. The $40.4M Markforged goodwill impairment signals the 2024 acquisition—their flagship FFF bet—is worth materially less than paid. Q1 revenue grew 106% YoY but that's entirely Markforged; standalone NNDM revenue fell 12%. They've divested AME/Fabrica, are selling another unnamed line, and now shopping the remainder to Houlihan Lokey. Cash burn improved but from a terrible baseline. The 'exciting opportunities' language masks a company that couldn't integrate acquisitions and is now liquidating them piecemeal. Shareholder Moshe's skepticism is warranted—this is the third strategic reset in 18 months.
If management executes a clean merger or reverse merger with a higher-quality operator, the $441M cash war chest and 45.9% gross margins on remaining product lines could create real value. The cost discipline is real: standalone opex down 22% YoY, sequential burn improving. A focused, smaller NNDM might trade at a less punitive multiple than the conglomerate discount it carries today.
"Near-term upside depends entirely on monetizing remaining product lines via uncertain deals; without concrete closures and favorable terms, the stock faces ongoing downside risk."
Opening read: Nano Dimension signals a three-pronged plan: streamline, monetize, and pursue go-forward alternatives. The near-term hinge is whether the remaining product lines can be monetized at credible valuations and favorable terms. Q1 revenue rose largely from Markforged; stand-alone revenue fell about 12% YoY, and EBITDA remained negative. The firm withdrew full-year guidance amid monetization uncertainty and booked a $40.4m goodwill impairment on Markforged. The plan is ambitious but opaque on timing, terms, and buyers. While cash burn has fallen to a roughly $9–10m quarterly run rate, a prolonged delay or a weak deal could leave the stock exposed to continued losses and potential dilution. Missing context: exact valuations, buyer pipelines, and regulatory timelines.
The strongest counter: even if monetization occurs, the upside could be limited if buyers value the lines below management's assumptions, and the three-phase plan risks becoming a narrative to delay real execution rather than a true value inflection.
"The company's history of poor capital allocation creates a 'governance discount' that makes their cash hoard a liability rather than a catalyst for shareholder value."
Claude and Gemini are right about the liquidation, but you're all ignoring the 'M&A poison' risk. NNDM’s history of aggressive, value-destructive acquisitions suggests management lacks the operational discipline to execute a reverse merger that doesn't just transfer their governance failures to a new entity. Even with $441M in cash, the 'conglomerate discount' isn't just about complexity—it's a 'governance discount.' Until the board is overhauled, that cash is a liability, not an asset.
"Governance risk diminishes in cash-shell transition, but tax leakage on divestments poses a larger, unaddressed threat to net liquidity."
Gemini, governance 'poison' is real history, but with $442M cash > market cap (0.7x book value discount), NNDM's shrinkage to a cash shell minimizes operational governance risks—board can't mismanage what's left. Unmentioned second-order risk: divestment tax hits (potentially 21% corp + state) could net 15-20% less cash, eroding the war chest before Phase 3. Focus here over endless M&A skepticism.
"Tax leakage on divestitures could reduce effective liquidity by $66-88M, materially weakening NNDM's negotiating position in Phase 3 M&A."
Grok flags the tax leakage risk—15-20% erosion on divestment proceeds—but undersells it. At $442M cash, losing $66-88M to federal + state taxes on asset sales materially compresses the 'war chest' thesis. That's not a second-order detail; it's the difference between 'enough dry powder for a credible reverse merger' and 'barely enough to cover burn while shopping assets.' Nobody's modeled this explicitly. It also means management has incentive to rush Phase 3 deals to minimize tax drag, which could force worse valuations.
"Phase 3 monetizations must fetch credible multiples, otherwise the cash hoard becomes a constraint, not an upside lever."
Grok, I grant tax leakage is material, but the bigger, under-discussed risk is the quality and timing of Phase 3 assets and the buyers' willingness to pay credible multiples. Even with $442M cash, a prolonged sale process could burn cash and depress valuations as buyers discount for governance risk, regulatory timing, and reliance on a few marquee buyers. The 'cash hoard' becomes a financing constraint, not an automatic upside lever.
Nano Dimension is effectively liquidating its operational identity, with a focus on monetizing assets and pursuing a reverse merger. The company's history of value-destructive acquisitions and governance issues raise significant concerns about its ability to execute a successful turnaround.
Monetizing the remaining product lines at credible valuations and favorable terms, which could provide the cash needed for a reverse merger and potentially turn the company around.
The 'M&A poison' risk, where management's lack of operational discipline could lead to another value-destructive acquisition or reverse merger, transferring their governance failures to a new entity.